Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Crystalvue Medical CoROCO:6527 -0.28%94 Interest Coverage is 520.97 as of Dec. 2025, which is 179% above its 10-year median of 186.65. GuruFocus rates ROCO:6527 with a GF Score™ of 94/100 and a GF Value™ of NT$95.37 (Modestly Undervalued). The stock has 1 warning sign investors should review. Among 466 Medical Devices & Instruments companies, Crystalvue Medical Co ranks better than 87.77% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Crystalvue Medical Co's
Operating Income
for the
three
months ended in Dec. 2025 was NT$47.9 Mil. Crystalvue Medical Co's Interest Expense for the
three
months ended in Dec. 2025 was NT$-0.1 Mil.
Crystalvue Medical Co's interest coverage for the quarter that ended in Dec. 2025 was 520.97.
The higher the ratio, the stronger the company's financial strength is.
Good Sign:
Ben Graham prefers companies' interest coverage to be at least 5. Crystalvue Medical Co Ltd has enough cash to cover all of its debt. Its financial situation is stable.
The historical rank and industry rank for Crystalvue Medical Co's Interest Coverage or its related term are showing as below:
ROCO:6527'
s Interest Coverage Range Over the Past 10 Years
Min: 42.9 Med: 186.65 Max: No Debt
Current: 399.44
ROCO:6527's Interest Coverage is ranked better than 87.77% of 466
companies
in the Medical Devices & Instruments industry
Industry Median: 16.08
vs ROCO:6527: 399.44
Crystalvue Medical Co (ROCO:6527) Interest Coverage Explanation
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Crystalvue Medical Co Interest Coverage Related Terms
Crystalvue Medical Co Interest Coverage Historical Data
* Premium members only.
The historical data trend for Crystalvue Medical Co's Interest Coverage can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
ROCO:6527 vs ISRG, BDX, MDLN: Interest Coverage Comparison
For the Medical Instruments & Supplies subindustry, Crystalvue Medical Co's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Crystalvue Medical Co Interest Coverage vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Crystalvue Medical Co's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Crystalvue Medical Co's Interest Coverage falls into.
Crystalvue Medical Co Interest Coverage Calculation
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Crystalvue Medical Co (ROCO:6527) has a Interest Coverage of 520.97 as of Dec. 2025. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Crystalvue Medical Co and its competitors. This is 179% above median its historical median of 186.65. Over the past decade, Crystalvue Medical Co's Interest Coverage has ranged from 42.90 to 10,000.00. According to the industry distribution chart, Crystalvue Medical Co ranks #57 out of 466 companies in the Medical Devices & Instruments industry, placing it in the top 12.2%.
Is Crystalvue Medical Co's Interest Coverage too high?
Crystalvue Medical Co's current Interest Coverage of 520.97 is 179% above median its 10-year median of 186.65. Over the past 10 years, this metric has ranged from a low of 42.90 to a high of 10,000.00. The Medical Devices & Instruments industry median Interest Coverage is 16.08. Crystalvue Medical Co's value of 520.97 is 3139.9% above this industry median. Based on the distribution chart, Crystalvue Medical Co ranks #57 out of 466 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Crystalvue Medical Co has a GF Score™ of 94/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Crystalvue Medical Co's Interest Coverage compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Crystalvue Medical Co ranks #57 out of 466 companies for Interest Coverage. This places Crystalvue Medical Co in the top 12% of its industry — outperforming the majority of peers. The industry median Interest Coverage is 16.08. Crystalvue Medical Co's value of 520.97 is 3139.9% above this benchmark. Historically, Crystalvue Medical Co's own Interest Coverage has ranged from 42.90 to 10,000.00 over the past decade. While the company's 10-year median is 186.65 vs. the industry median of 16.08, Crystalvue Medical Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Medical Devices & Instruments company?
The median Interest Coverage among Medical Devices & Instruments companies is 16.08, based on 466 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Crystalvue Medical Co's current Interest Coverage of 520.97 is 3139.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Crystalvue Medical Co and its competitors. For the Medical Devices & Instruments industry, the median Interest Coverage is 16.08 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Crystalvue Medical Co's current Interest Coverage is 520.97, which is 179% above median its own 10-year median of 186.65. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Crystalvue Medical Co stock overvalued right now?
Based on GuruFocus' analysis, Crystalvue Medical Co (ROCO:6527) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$95.37, compared to a current price of NT$71.00 — trading 25.6% below its estimated fair value. The current Interest Coverage is 520.97, which is 179% above median its 10-year median of 186.65 and 3139.9% above the Medical Devices & Instruments industry median of 16.08. Crystalvue Medical Co's overall GF Score™ is 94/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Crystalvue Medical Co (ROCO:6527), the current Interest Coverage is 520.97 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Crystalvue Medical Co (ROCO:6527) Overvalued in 2026?
Based on GuruFocus' analysis, Crystalvue Medical Co stock appears to be undervalued.
The current stock price of NT$71.00 is trading 25.6% below its estimated GF Value™ of NT$95.37.
GuruFocus considers Crystalvue Medical Co to be Modestly Undervalued.
Key valuation signals for ROCO:6527:
Interest Coverage: 520.97 (179% above median its 10-year median of 186.65)
GF Value™: NT$95.37 vs. price of NT$71.00 (25.6% below fair value)
Industry Position: 3139.9% above the Medical Devices & Instruments median (#57 of 466)
No single metric tells the full story. See the ROCO:6527 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Crystalvue Medical Co Ltd is engaged in the manufacture and sale of medical devices. Its products include fundus cameras, optical coherence tomography (OCT) systems, tonometers, digital microscope cameras, lens edgers, and gastrointestinal endoscopic disposable devices, among others.
94GF Score
Get the complete analysis for ROCO:6527
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:6527 has been successfully added to your 
